HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview.

Abstract
This note overviews several studies that have been conducted on the economic impact of onchocerciasis (river blindness) control through the African Programme for Onchocerciasis Control (APOC). A cost-benefit analysis of the APOC concludes that the programme is highly cost-effective. The economic rate of return (ERR) is 17% if benefits are considered in accordance with the stated objective of the programme (i.e. the achievement of long-term, sustainable, ivermectin-delivery systems). However, the cost-benefit analysis significantly under-estimates the net benefits from the APOC, since it considers, for ease of quantification, only the reduction in blindness as the principal benefit accruing from control activities. Recent studies, summarized here, have shown that there may be substantial benefits (in terms of enhanced productivity, increased household-level welfare, and reduced health-related expenditure, for instance) resulting from the reduction of the skin-related symptoms associated with the disease.
AuthorsB Benton
JournalAnnals of tropical medicine and parasitology (Ann Trop Med Parasitol) Vol. 92 Suppl 1 Pg. S33-9 (Apr 1998) ISSN: 0003-4983 [Print] England
PMID9861265 (Publication Type: Journal Article, Review)
Chemical References
  • Filaricides
  • Ivermectin
Topics
  • Africa
  • Cost-Benefit Analysis (economics)
  • Filaricides (economics, therapeutic use)
  • Health Care Costs
  • Humans
  • Ivermectin (economics, therapeutic use)
  • Onchocerciasis (economics, prevention & control)
  • Program Evaluation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: